⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of HEOR and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
HEOR
↗Cardiff, United Kingdom
HEOR is an independent market access consultancy established in 2011. The company specializes in health economic modelling, statistical analysis, evidence generation, and value communication services for the biopharmaceutical industry, helping clients navigate complex reimbursement landscapes and health technology assessments (HTA).
The firm operates with a focus on scientific rigour and academic excellence, providing bespoke solutions for global market access. They maintain a hybrid working model with offices in Cardiff and Oxfordshire, and additional flexible space in London and northern England.
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:
Industry:CRO
Sub-Industry:Market Access & Health Economics Consulting
SIZE & FINANCIALS
Employees:51-200
Founded:2011
Ownership:private
Status:operating
0
CORPORATE STRUCTURE
Key Partnerships:Large biopharma and smaller biotech firms globally
COMPETITION
Position:Niche Player
Competitors:OPEN Health, Abacus Medicine, Target RWE
LEADERSHIP
Key Executives:
Frank Holmes - Non-Executive Director
Board Members:Frank Holmes, Eamus Halpin, Cat Oyler Rivers
LINKS
Website:heor.co.uk
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with HEOR. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.